These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 20236684)

  • 1. Metaplastic carcinoma of the breast.
    Okada N; Hasebe T; Iwasaki M; Tamura N; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kanai Y; Kinoshita T
    Hum Pathol; 2010 Jul; 41(7):960-70. PubMed ID: 20236684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
    Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ
    Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
    Sullivan PS; Apple SK
    Breast J; 2009; 15(2):146-54. PubMed ID: 19292800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases.
    Carter MR; Hornick JL; Lester S; Fletcher CD
    Am J Surg Pathol; 2006 Mar; 30(3):300-9. PubMed ID: 16538049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics.
    Nagao T; Kinoshita T; Hojo T; Tsuda H; Tamura K; Fujiwara Y
    Breast; 2012 Jun; 21(3):289-95. PubMed ID: 22277312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective matched-pair comparison of outcome after treatment for lobular and ductal breast carcinoma.
    Mhuircheartaigh JN; Curran C; Hennessy E; Kerin MJ
    Br J Surg; 2008 Jul; 95(7):827-33. PubMed ID: 18498127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology.
    Moran MS; Yang Q; Haffty BG
    Breast J; 2009; 15(6):571-8. PubMed ID: 19995377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Important histologic outcome predictors for patients with invasive ductal carcinoma of the breast.
    Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Kinoshita T; Tsuda H
    Am J Surg Pathol; 2011 Oct; 35(10):1484-97. PubMed ID: 21881484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying patients at risk of compromised margins following breast conservation for lobular carcinoma.
    Dillon MF; Hill AD; Fleming FJ; O'Doherty A; Quinn CM; McDermott EW; O'Higgins N
    Am J Surg; 2006 Feb; 191(2):201-5. PubMed ID: 16442946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
    Sinha PS; Bendall S; Bates T
    Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.
    Vo TN; Meric-Bernstam F; Yi M; Buchholz TA; Ames FC; Kuerer HM; Bedrosian I; Hunt KK
    Am J Surg; 2006 Oct; 192(4):552-5. PubMed ID: 16978974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast.
    Hasebe T; Yamauchi C; Iwasaki M; Ishii G; Wada N; Imoto S
    Hum Pathol; 2008 Mar; 39(3):427-36. PubMed ID: 18261627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution series.
    Viale G; Rotmensz N; Maisonneuve P; Orvieto E; Maiorano E; Galimberti V; Luini A; Colleoni M; Goldhirsch A; Coates AS
    Breast Cancer Res Treat; 2009 Sep; 117(1):211-4. PubMed ID: 18629634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy.
    Hwang N; Schiller DE; Crystal P; Maki E; McCready DR
    Ann Surg Oncol; 2009 Nov; 16(11):3000-9. PubMed ID: 19603233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive lobular carcinoma of the breast: role of endothelial lymphatic marker D2-40.
    Laser J; Cangiarella J; Singh B; Melamed J; Chiriboga L; Yee H; Darvishian F
    Ann Clin Lab Sci; 2008; 38(2):99-104. PubMed ID: 18469353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nottingham grades of lobular carcinoma lack the prognostic implications they bear for ductal carcinoma.
    Wachtel MS; Halldorsson A; Dissanaike S
    J Surg Res; 2011 Mar; 166(1):19-27. PubMed ID: 20828724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.
    Bharat A; Gao F; Margenthaler JA
    Am J Surg; 2009 Oct; 198(4):516-9. PubMed ID: 19800459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.